Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-03-01 @ 9:59 AM
Study NCT ID:
NCT02105467
Status:
COMPLETED
Last Update Posted:
2018-10-02
First Post:
2014-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2015-02-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09-06
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-02
First Submit QC Date:
None
Study First Post Date:
2014-04-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-03
Results First Submit QC Date:
None
Results First Post Date:
2016-04-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-03
Last Update Post Date:
2018-10-02
Last Update Post Date Type:
ACTUAL